tiprankstipranks
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX

Quoin Pharmaceuticals (QNRX) Financial Statements

247 Followers

Quoin Pharmaceuticals Financial Overview

Quoin Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-8.794; its P/E ratio is -0.08; Quoin Pharmaceuticals is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -1.93M$ -2.11M$ -2.60M-$ -2.32M
EBITDA$ -1.90M$ -2.08M$ -2.58M-$ -2.29M
Net Income Common Stockholders$ -1.93M$ -2.11M$ -2.60M-$ -3.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.20M$ 4.80M$ 3.40M$ 2.86M$ 15.16M
Total Assets$ 15.07M$ 16.71M$ 18.48M$ 14.46M$ 16.44M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.20M$ -4.80M$ -3.40M$ -2.86M$ -15.16M
Total Liabilities$ 7.65M$ 7.64M$ 7.54M$ 7.05M$ 7.27M
Stockholders Equity$ 7.41M$ 9.07M$ 10.91M$ 7.41M$ 9.17M
Cash Flow-
Free Cash Flow$ -1.30M$ -1.55M$ -1.75M-$ -2.29M
Operating Cash Flow$ -1.30M$ -1.55M$ -1.75M-$ -2.29M
Investing Cash Flow$ 821.00$ 3.04M$ -3.49M-$ -9.90M
Financing Cash Flow$ -275.00K$ -75.00K$ 5.75M-$ 14.75M
Currency in USD

Quoin Pharmaceuticals Earnings and Revenue History

Quoin Pharmaceuticals Debt to Assets

Quoin Pharmaceuticals Cash Flow

Quoin Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis